COMMD4 and non-small cell lung carcinoma: As the combination of COMMD4 depletion and either irradiation or camptothecin was shown to be synergistic in NSCLC, COMMD4 inhibition in combination therapy with agents that cause DNA damage may prove to be an attractive treatment option for NSCLC patients.